Skip to main content
VERU INC. logo

VERU INC. — Investor Relations & Filings

Ticker · VERU ISIN · US92536C1036 LEI · 529900ER63TFLEIJV631 US Manufacturing
Open in API
Filings indexed 1,019 across all filing types
Latest filing 2026-05-13 Share Issue/Capital Cha…
Country US United States of America
Listing US VERU

About VERU INC.

https://verupharma.com/

Veru Inc. is a late-stage biopharmaceutical company focused on developing and commercializing treatments for cardiometabolic and inflammatory diseases. The company's primary development programs address high-quality weight loss and atherosclerotic coronary artery disease. Its lead candidate, enobosarm, is a novel, oral selective androgen receptor modulator (SARM) designed to prevent muscle loss in patients undergoing weight loss therapy with GLP-1 receptor agonists. Veru is also advancing sabizabulin, an oral broad anti-inflammatory agent, for the treatment of atherosclerotic coronary artery disease.

Recent filings

Filing Released Lang Actions
S-8 - VERU INC. (0000863894) (Filer)
Share Issue/Capital Change Classification · 92% confidence The document is a Form S-8 registration statement filed with the SEC under the Securities Act of 1933 to register additional shares of common stock under the Veru Inc. 2018 Equity Incentive Plan. This filing concerns the issuance of new shares under an equity plan, matching the description for Share Issue/Capital Change (SHA).
2026-05-13 English
10-Q - VERU INC. (0000863894) (Filer)
Interim / Quarterly Report Q2 2026
2026-05-13 English
8-K - VERU INC. (0000863894) (Filer)
Earnings Release Classification · 82% confidence The document is a Form 8-K filed to furnish a press release announcing quarterly and six-month financial results for the period ended March 31, 2026. This is a classic earnings release disclosure rather than the full interim report or just a notice of report publication. It provides initial highlights of financial results, meeting the definition of an Earnings Release (ER). H1 2026
2026-05-13 English
Regulatory Filings 2026
Regulatory Filings
2026-04-16 English
Regulatory Filings 2026
Regulatory Filings
2026-04-16 English
S-3 - VERU INC. (0000863894) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is a registration statement used for securities offerings under the Securities Act of 1933. It includes detailed information about the securities to be offered, such as common stock, debt securities, preferred stock, warrants, and other instruments. The document is not a financial report, earnings release, or management discussion, but rather a capital markets filing related to fundraising and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement or a certification, so it is not RPA or RNS. Hence, the classification is CAP with high confidence.
2026-04-07 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.